chr2-233199308-A-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001017915.3(INPP5D):​c.2975+932A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00663 in 103,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0066 ( 0 hom., cov: 22)

Consequence

INPP5D
NM_001017915.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0850

Publications

3 publications found
Variant links:
Genes affected
INPP5D (HGNC:6079): (inositol polyphosphate-5-phosphatase D) This gene is a member of the inositol polyphosphate-5-phosphatase (INPP5) family and encodes a protein with an N-terminal SH2 domain, an inositol phosphatase domain, and two C-terminal protein interaction domains. Expression of this protein is restricted to hematopoietic cells where its movement from the cytosol to the plasma membrane is mediated by tyrosine phosphorylation. At the plasma membrane, the protein hydrolyzes the 5' phosphate from phosphatidylinositol (3,4,5)-trisphosphate and inositol-1,3,4,5-tetrakisphosphate, thereby affecting multiple signaling pathways. The protein is also partly localized to the nucleus, where it may be involved in nuclear inositol phosphate signaling processes. Overall, the protein functions as a negative regulator of myeloid cell proliferation and survival. Mutations in this gene are associated with defects and cancers of the immune system. Deficiencies in the encoded protein, SHIP1, have been associated with Inflammatory Bowel Disease types such as Crohn's Disease and Ulcerative Colitis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Variant has high frequency in the SAS (0.00737) population. However there is too low homozygotes in high coverage region: (expected more than 1, got 0).
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001017915.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INPP5D
NM_001017915.3
MANE Select
c.2975+932A>G
intron
N/ANP_001017915.1
INPP5D
NM_005541.5
c.2972+932A>G
intron
N/ANP_005532.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INPP5D
ENST00000445964.6
TSL:1 MANE Select
c.2975+932A>G
intron
N/AENSP00000405338.2
INPP5D
ENST00000359570.9
TSL:1
c.2972+932A>G
intron
N/AENSP00000352575.7
INPP5D
ENST00000415617.5
TSL:5
c.1838+932A>G
intron
N/AENSP00000397421.1

Frequencies

GnomAD3 genomes
AF:
0.00662
AC:
683
AN:
103180
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00523
Gnomad AMI
AF:
0.00207
Gnomad AMR
AF:
0.00562
Gnomad ASJ
AF:
0.00838
Gnomad EAS
AF:
0.00285
Gnomad SAS
AF:
0.00877
Gnomad FIN
AF:
0.00471
Gnomad MID
AF:
0.0149
Gnomad NFE
AF:
0.00805
Gnomad OTH
AF:
0.00611
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00663
AC:
684
AN:
103234
Hom.:
0
Cov.:
22
AF XY:
0.00644
AC XY:
323
AN XY:
50174
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00522
AC:
145
AN:
27790
American (AMR)
AF:
0.00562
AC:
59
AN:
10506
Ashkenazi Jewish (ASJ)
AF:
0.00838
AC:
22
AN:
2624
East Asian (EAS)
AF:
0.00285
AC:
12
AN:
4212
South Asian (SAS)
AF:
0.00881
AC:
28
AN:
3178
European-Finnish (FIN)
AF:
0.00471
AC:
29
AN:
6156
Middle Eastern (MID)
AF:
0.0160
AC:
3
AN:
188
European-Non Finnish (NFE)
AF:
0.00805
AC:
375
AN:
46606
Other (OTH)
AF:
0.00671
AC:
10
AN:
1490
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.287
Heterozygous variant carriers
0
57
113
170
226
283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0696
Hom.:
4

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
2.2
DANN
Benign
0.22
PhyloP100
0.085

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12987960; hg19: chr2-234107954; API